Literature DB >> 9803070

Oral diadochokinetic rate in adults.

B Prathanee1.   

Abstract

Diadochokinetic rate has traditionally been used for assessment, diagnosis and therapy in patients who suffered from oral cancer resection, glossectomy, oral myofunctional disease, dysphagia, dysarthria, functional articulation disorders or apraxia of speech. This is because diadochokinetic rate shows the documented structural and physiological changes in the central nervous system and the peripheral components of oral and speech production mechanism. Diadochokinetic rates were obtained from seventy-six normal subjects by counting the repetition of oral function (/a:-u:/; /u:-i:/; and /i:-a:/), tongue function (tongue movement from side to side of lip corner and lan lan lan lan la), and lip-tongue function (/p-t-k/ and /ph-th-kh/) in 15 seconds. The Count-by-Time test was used for data collection. The finding showed average diadochokinetic rates (syllables or times per 15 seconds) were 33.6, 33.16, 30.58; 24.21, 15.10, 26.50 and 26.30 for /a:-u:/, /u:-i:/, /i:-a:/, tongue movement from side to side of lip corner, lan lan lan lan la, /p-t-k/, and /ph-th-kh/. Most of the correlation analysis showed a high positive relationship. The results of this study are guidelines of normal diadochokinetic rates. In addition, they can indicate the severity of diseases and evaluation of treatment.

Entities:  

Mesh:

Year:  1998        PMID: 9803070

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  2 in total

1.  Oral and vocal fold diadochokinesis in dysphonic women.

Authors:  Talita Louzada; Roberta Beraldinelle; Giédre Berretin-Felix; Alcione Ghedini Brasolotto
Journal:  J Appl Oral Sci       Date:  2011 Nov-Dec       Impact factor: 2.698

2.  Prevalence of an incompetent lip seal during growth periods throughout Japan: a large-scale, survey-based, cross-sectional study.

Authors:  Yukiko Nogami; Issei Saitoh; Emi Inada; Daisuke Murakami; Yoko Iwase; Naoko Kubota; Yuki Nakamura; Masami Kimi; Haruaki Hayasaki; Youichi Yamasaki; Yasutaka Kaihara
Journal:  Environ Health Prev Med       Date:  2021-01-21       Impact factor: 3.674

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.